Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma

Clinical trial NCT03995147 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03995147
Sponsor: University of Chicago
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

B Cell Lymphoma Lymphoma Lymphoma, B-Cell Diffuse Large B Cell Lymphoma High-grade B-cell Lymphoma

Start date: 2019-08-29
Primary completion: 2027-02-20
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.